Abstract
To review the data sources of health-state utility values (HSUVs), as well as their elicitation and use, in 140 breast cancer-related cost-utility analyses (CUAs), and to provide a critical appraisal of these. A checklist was developed to guide the process of the critical appraisal. It is divided into three parts: the data source (three questions), elicitation method (four questions), and use (ten questions) of HSUVs in CUAs. Two independent reviewers performed the data extraction. A consensus was reached in case of disagreements. Data sources were categorized as "original study," "derived from the literature," or "other." The data source of HSUVs was always specified. When HSUVs were derived from the literature (90% of cases), the authors referred to a median number of two references as data sources. The critical appraisal of the elicitation of HSUVs in CUAs revealed considerable variability in terms of the quality of the reporting of the data source selection of HSUV. More details were provided by authors when HSUVs were elicited from an original study rather than derived from the literature. The use of HSUVs elicited from an original study was generally better described in terms of the checklist than were those derived from ...Continue Reading
References
Jul 1, 1996·Medical Care·G W TorranceQ Wang
May 8, 1995·PharmacoEconomics·G W TorranceM Boyle
Jun 6, 1996·Health Policy·R Brooks
Apr 10, 2002·Journal of Health Economics·John BrazierMark Deverill
Sep 8, 2005·Expert Opinion on Pharmacotherapy·Agnes Benedict, Ruth E Brown
May 2, 2007·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·David Moher
Mar 29, 2008·PharmacoEconomics·Paul A ScuffhamRosalie Viney
Oct 19, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Tessa PeasgoodJohn Brazier
Jan 8, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jonathan C ToshElisabeth George
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
Nov 15, 2011·Lancet·Melanie CalvertMichael Brundage
Jul 7, 2012·Future Oncology·John R Benson, Ismail Jatoi
Feb 26, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Bonny ParkinsonRosalie Viney
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Melanie CalvertUNKNOWN CONSORT PRO Group
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Oct 17, 2015·American Journal of Preventive Medicine·Aaron N WinnPeter J Neumann
Mar 30, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael HerdmanNancy Devlin
Aug 31, 2016·Breast Cancer Research and Treatment·Virginie NerichBernhard Holzner
Citations
Jan 23, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·V BrownM L Moodie
Mar 25, 2019·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Feng XieGordon Guyatt
Jun 17, 2020·Applied Health Economics and Health Policy·Virginie NerichGeorg Kemmler
Jul 15, 2020·Applied Health Economics and Health Policy·Ru HanMondher Toumi
Apr 12, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael J ZorattiUNKNOWN Health Utility Book (HUB) Working Group
Jul 5, 2021·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Anna MiroshnychenkoAchilleas Thoma